The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells
Momeny, Majid, Esmaeili, Fatemeh, Hamzehlou, Sepideh, Yousefi, Hassan, Javadikooshesh, Sepehr, Vahdatirad, Vasimeh, Alishahi, Zivar, Mousavipak, Seyedeh H., Bashash, Davood, Dehpour, Ahmad R., Tavangar, Seyyed M., Tavakkoly-Bazzaz, Javad, Haddad, Peiman, Kordbacheh, Farzaneh, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Published in Cellular oncology (Dordrecht) (01.08.2019)
Published in Cellular oncology (Dordrecht) (01.08.2019)
Get full text
Journal Article